An oncological view on the blood–testis barrier
- 1 June 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (6), 357-363
- https://doi.org/10.1016/s1470-2045(02)00776-3
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Death Receptors: Signaling and ModulationScience, 1998
- Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.Journal of Clinical Investigation, 1998
- Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978–1994British Journal of Urology, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10-year follow-up studyMedical and Pediatric Oncology, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimerasDevelopmental Biology, 1981